Spyre Therapeutics, Inc. (SYRE)
Market Open
16 Oct, 04:22 PM
$
80. 08
-0.02
-0.0275%
$
6.94B Market Cap
- P/E Ratio
- Div Yield
337,303 Volume
- Eps
$ 80.1
Previous Close 
Want to track SYRE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Spyre Therapeutics, Inc. (SYRE) Statistics
Valuation metrics
Market Cap 6.94B
Enterprise value 7.28B
Trailing P/E (ttm) -43.94
Forward P/E -
PEG ratio 0.86
Price/Sales (ttm) 82.23
Price/Book (mrq) 6.59
Enterprise Value/Revenue 80.44
Enterprise Value/EBITDA -39.23
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.39M
Average volume (90 days) 1.7M
Price summary
52-Week low 21.14
52-Week high 110.18
Beta -
50-Day moving average 89.35
200-Day moving average 69.1
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 8 Sep 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.98%
Operating margin -2.22%
Operational effectiveness
Return on assets -0.15%
Return on equity -0.24%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.07
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.11
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 13.52
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 18.53%
Book value per share (mrq) 13
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
